Search Results 151-160 of 17174 for CLL

  1. Publications

    Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood Cancer J 2021 ...

  2. Clinical trials - Rheumatology

    ... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...

  3. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  4. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  5. Talal Hilal, M.D. - Doctors and Medical Staff - Mayo Clinic

    Talal Hilal, M.D., is a hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid ...

  6. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  7. Duvelisib (oral route) - Side effects & dosage - Mayo Clinic

    Duvelisib is used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or after 2 or more types of treatment that ...

  8. Idelalisib (oral route) - Side effects & dosage - Mayo Clinic

    Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes ...

  9. Fludarabine (intravenous route) - Side effects & uses - Mayo Clinic

    It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL ...

  10. Hematology - Clinical trials

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...